Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002541671 | SCV003690304 | uncertain significance | Inborn genetic diseases | 2021-04-28 | criteria provided, single submitter | clinical testing | The c.709G>A (p.A237T) alteration is located in exon 9 (coding exon 9) of the RARS2 gene. This alteration results from a G to A substitution at nucleotide position 709, causing the alanine (A) at amino acid position 237 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001278029 | SCV001465021 | uncertain significance | Pontocerebellar hypoplasia type 6 | 2020-09-04 | no assertion criteria provided | clinical testing |